| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-14 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-12 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-12 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-09 |